课题基金 / 基金详情

BIOCHEMICAL MODULATION OF 5-FLUOROURACIL AND LEUCOVORIN IN COLORECTAL CANCER

BIOCHEMICAL MODULATION OF 5-FLUOROURACIL AND LEUCOVORIN IN COLORECTAL CANCER
5-氟尿嘧啶和亚叶酸在结直肠癌中的生化调节
批准号：
5225569
负责人：
HYMAN MUSS
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5225569
关键词：
N phosphonoacetyl L aspartate clinical research colorectal neoplasms combination chemotherapy drug resistance drug screening /evaluation fluorouracil human subject human therapy evaluation leucovorin neoplasm /cancer chemotherapy

项目摘要

项目成果

HYMAN MUSS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The development or resistance to anti-cancer drugs is the principal cause of chemotherapy failure in cancer patients. The goal of this study is to increase the response to the anti-cancer agent 5-fluorouracil by overcoming tumor cell resistance with a second anti-cancer agent PALA. This study uses a 3X3 factorial design to assess the joint effects of PALA, leucovorin and fluorouracil on various biochemical endpoints in patients with resectable colorectal cancer. The results will provide a basis for improving therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biomarkers of Molecular Age to Predict the Toxicity of Cancer Chemotherapy
CORE--CLINICAL RESEARCH MANAGEMENT
CLINICAL RESEARCH
CORE--CLINICAL RESEARCH MANAGEMENT
海外基金